Literature DB >> 4949490

Immune response to sheep red blood cells in mice pretreated with mycobacterial fractions.

A Bekierkunst, E Yarkoni, I Flechner, S Morecki, E Vilkas, E Lederer.   

Abstract

Ten micrograms of trehalose-6,6' -dimycolate (cord factor) injected into the footpads of mice increased the antibody response to sheep red blood cells (SRBC) subsequently injected into the same sites. There is a relationship between the antibody response and the cellular reaction induced locally and in the draining lymph nodes by cord factor, as judged by a much weaker response when antigen is injected into the contralateral footpads. The time intervals between injection of cord factor and antigen were from 5 to 20 days. A similar increased antibody response to SRBC was evident after preliminary administration of Freund's complete adjuvant or living BCG bacilli into the footpads. There was no increased antibody response in mice pretreated with living BCG or Freund's adjuvant to SRBC injected into the contralateral footpads. Administration of wax D from human strains Peurois and Test was without any effect. Administration of SRBC emulsified in incomplete Freund's adjuvant containing 5 mug of cord factor induced a very strong antibody response in the mice as compared to that after injection of the same amount of antigen in incomplete Freund's adjuvant containing wax D or mycobacteria. The results are discussed.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4949490      PMCID: PMC416297          DOI: 10.1128/iai.4.3.256-263.1971

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  15 in total

1.  Effect of mycobacteria on antibody production induced by water-in-oil emulsions of soluble protein antigens.

Authors:  W O WEIGLE; F J DIXON; M P DEICHMILLER
Journal:  Proc Soc Exp Biol Med       Date:  1960-12

2.  Formation of specific antibodies and gamma-globulin in vitro; a study of the synthetic ability of various tissues from rabbits immunized by different methods.

Authors:  B A ASKONAS; J H HUMPHREY
Journal:  Biochem J       Date:  1958-02       Impact factor: 3.857

3.  The mode of action of immunologic adjuvants.

Authors:  J FREUND
Journal:  Bibl Tuberc       Date:  1956

4.  Sites of antibody production in the guinea-pig; the relation between in vitro synthesis of anti-ovalbumin and gamma-globulin and distribution of antibody-containing plasma cells.

Authors:  B A ASKONAS; R G WHITE
Journal:  Br J Exp Pathol       Date:  1956-02

5.  Suppression by cortisone of granuloma formation and antibody in guinea pigs receiving egg albumin with Freund adjuvants.

Authors:  E E FISCHEL; E A KABAT; H C STOERK; M SKOLNICK; A E BEZER
Journal:  J Allergy       Date:  1954-05

Review 6.  Endotoxins and the immune response.

Authors:  E Neter
Journal:  Curr Top Microbiol Immunol       Date:  1969       Impact factor: 4.291

Review 7.  Cellular hypersensitivity and cellular immunity in the pathogensis of tuberculosis: specificity, systemic and local nature, and associated macrophage enzymes.

Authors:  A M Dannenberg
Journal:  Bacteriol Rev       Date:  1968-06

8.  Recent studies on acquired immunity in tuberculosis.

Authors:  G P Youmans; A S Youmans
Journal:  Curr Top Microbiol Immunol       Date:  1969       Impact factor: 4.291

9.  Histological changes evoked in mice by Freund's complete adjuvant.

Authors:  R L Carter; D G Jamison; R L Vollum
Journal:  J Pathol       Date:  1969-03       Impact factor: 7.996

10.  Cellular reaction in the footpad and draining lymph nodes of mice induced by mycobacterial fractions and BCG bacilli.

Authors:  A Bekierkunst; I S Levij; E Yarkoni; E Vilkas; E Lederer
Journal:  Infect Immun       Date:  1971-09       Impact factor: 3.441

View more
  28 in total

1.  Stimulation of lymphocyte proliferation by killed mycobacteria and other bacterial species.

Authors:  A Bekierkunst
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

2.  Granuloma formation in lungs of mice after intravenous administration of emulsified trehalose-6,6'-dimycolate (cord factor): reaction intensity depends on size distribution of the oil droplets.

Authors:  E Yarkoni; H J Rapp
Journal:  Infect Immun       Date:  1977-11       Impact factor: 3.441

3.  Preparation of arthritogenic hydrosoluble peptidoglycans from both arthritogenic and non-arthritogenic bacterial cell walls.

Authors:  O Kohashi; C M Pearson; Y Watanabe; S Kotani
Journal:  Infect Immun       Date:  1977-06       Impact factor: 3.441

4.  Adjuvant effects of trehalose dimycolate on the antibody response to type III pneumococcal polysaccharide.

Authors:  P J Baker; M B Fauntleroy; P W Stashak; J R Hiernaux; J L Cantrell; J A Rudbach
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

5.  Nonspecific immunostimulant activities of synthetic trehalose-6,6'-diesters (lower homologs of cord factor).

Authors:  M Parant; F Audibert; F Parant; L Chedid; E Soler; J Polonsky; E Lederer
Journal:  Infect Immun       Date:  1978-04       Impact factor: 3.441

Review 6.  Mycobacterial lipids: selected topics.

Authors:  M B Goren
Journal:  Bacteriol Rev       Date:  1972-03

7.  Granulomatous hypersensitivity to trehalose-6,6'-dimycolate (cord factor) in mice infected with BCG.

Authors:  A Bekierkunst; E Yarkoni
Journal:  Infect Immun       Date:  1973-04       Impact factor: 3.441

8.  Regression of a transplanted guinea pig hepatoma after intralesional injection of an emulsified mixture of endotoxin and mycobacterial sulfolipid.

Authors:  E Yarkoni; M B Goren; H J Rapp
Journal:  Infect Immun       Date:  1979-05       Impact factor: 3.441

9.  Nonspecific resistance against infection with Salmonella typhi and Salmonella typhimurium induced in mice by cord factor (trehalose-6,6'-dimycolate) and its analogues.

Authors:  E Yarkoni; A Bekierkunst
Journal:  Infect Immun       Date:  1976-11       Impact factor: 3.441

10.  Mincle is a long sought receptor for mycobacterial cord factor.

Authors:  Isamu Matsunaga; D Branch Moody
Journal:  J Exp Med       Date:  2009-12-14       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.